Press Release
West Red Lake Gold Generates July Gold Sales of CND $164 Million in Madsen Mine Ramp-up Phase
In July 2025, three gold pours were made at Madsen, producing a total of 3,800 ounces of gold. Of that, 3,595 ounces were sold at an average price of US$3,320 per oz, which generated CND $16.4 million in revenue.
Vancouver, BC, August 7, 2025 – Global Stocks News – Sponsored content disseminated on behalf of West Red Lake Gold. On August 6, 2025, West Red Lake Gold Mines (TSXV: WRLG) (OTCQB: WRLGF) provided an update on ramp-up activities at the Madsen Mine in Red Lake, Ontario.
In July 2025, three gold pours were made at Madsen, producing a total of 3,800 ounces of gold. Of that, 3,595 ounces were sold at an average price of US$3,320 per oz, which generated CND $16.4 million in revenue.
The company currently has a dual focus: 1. Achieving targeted ramp-up gold ounce production, 2. Instituting new operational efficiencies.
“July was a good month for Madsen and our mine operations team,” stated Shane Williams, WRLG President and CEO. “Mine ramp-up is about adding equipment, developing access to high-priority mining areas, and increasing operational efficiency until the mine consistently produces the targeted daily tonnage at the targeted grade.”
In July the Madsen mine operations team completed sill development and mining in eight (8) areas spread across McVeigh, South Austin, and Austin. Mined material carried an average grade of 8.9 grams per tonne gold.
Figure 1. Long section of the Madsen Mine showing the eight areas of active mining, sill development, and access development through the month of July 2025.
“Our continued operational success through bulk sample and now ramp-up demonstrates that we understand the geology and how to mine the orebody,” Maurice Mostert, WRLG VP of Technical Services told Guy Bennett, CEO of Global Stocks News (GSN). “As a company, we are conservative by nature. With our density of drilling, we’ve mitigated risk significantly.”
“In numerous cases, where we’ve expected to find the edge of a zone, further drilling has grown that zone,” continued Mostert. “That means we don’t have to urgently develop to a new area to reach our ounce-production goals. The mineralisation is right in our existing backyard.”
“We are not in full commercial production yet,” added Mostert. “The mill is permitted for 800 tonnes per day, but we are still ramping up to that target. On the days of lower production, we are doing maintenance on the mill. In full commercial production, we anticipate steady mill performance.”
Stope areas at Madsen are drill tested to 7-metre spacing. Sills, which are the access levels developed above and below stopes to create access to the mine, are not always drilled to 7-metre spacing because of stope and drill bay geometry.
“In July we saw the short-term resource model doing its job: stope grades reconciled closely to predicted model grades, and in fact exceeded planned grades in many cases,” said Jill Christmann, Madsen Mine Chief Geologist.
In addition, chip sampling along sills adds data to the model before stopes are mined. As a result of these two factors, sills are expected to return higher grade variability versus the model than stopes.
Such variability is shown in the figure below, which shows the number of sill development rounds that were expected to generate high grade (red), low grade (green), and waste (blue) material and the actual grades achieved for each kind of material.
WRLG is working on two projects to support further mine ramp-up and operational stability for the balance of the year.
Shaft Renovation
To prepare the Madsen Shaft to return to skipping material, West Red Lake Gold developed a 3-stage plan, with stage 1 to be implemented by year-end.
“The ‘skipped material’ is brought up the shaft in a big bucket called ‘the skip’,” Mostert told GSN. “Transporting material this way reduces costs and saves time, because you don’t have to drive the material up through the network of underground tunnels, from level 12 to surface.”
To achieve stage 1 skipping the company purchased a new hoist rope, a 5-tonne skip, and scrolls. Once phase 1 is complete with this new equipment, the shaft will be able to move approximately 300-400 tonnes of material to surface a day. These tonnes will be additive to the current material moving capacity.
Cemented Rock Fill (CRF) Project
Ore and waste must both be moved in a mine. The less waste that must be brought to surface, the better for a mine’s costs and efficiency.
Most historic stopes at Madsen are backfilled, but there are also a number of large empty stopes. These voids are ideal repositories for waste rock. To utilize such voids effectively, waste rock must be turned into Cemented Rock Fill (CRF).
“To restore the geotechnical strength of excavated stopes, we take broken rock and put it back to solidify the structures,” Mostert told GSN. “With CRF, you cure the loose rock with a cement binder content. The intended result is that you can eventually mine very close to the filled stope.”
Moving waste rock from where it is generated underground to these voids, rather than to surface, will free up significant haulage capacity.
Figure 5. A long section of the Madsen Mine showing historic mining. Remnant open stopes that West Red Lake Gold has identified as potentially suited for CRF waste rock storage are highlighted in yellow.
“Mine ramp ups are always balancing two competing needs: producing planned ounces in a given month and developing to ensure the ability to continue producing planned ounces in the months ahead,” said Williams. “Positive surprises, like the high-grade sills we encountered several times in July, make it easier to achieve that balance. July therefore helped set us up for success in the coming months.
The mine plan in the Madsen Mine Pre-Feasibility Study (PFS) [1] used a gold price of US$1,680 per oz – about 50% of the current gold price. This led to a mine plan with 60% of the mining being small, high-grade stopes requiring the use of cut-and-fill mining, which is selective and relatively high cost. [2]
For its current mine design, West Red Lake Gold is using the “consensus long-term price” of US$2,350 per ounce – a conservative number about $1,000 per ounce below the current gold price.
The technical information presented in this release has been reviewed and approved by Will Robinson, P.Geo., Vice President of Exploration for West Red Lake Gold and the Qualified Person for exploration at the West Red Lake Project, and by Maurice Mostert, P.Eng., Vice President of Technical Services Maurice for West Red Lake Gold and the Qualified Person for technical services at the West Red Lake Project, as defined by National Instrument 43-101 – Standards of Disclosure for Mineral Projects.
Contact: guy.bennett@globalstocksnews.com
Disclaimer: West Red Lake Gold paid Global Stocks News (GSN) $1,750 for the research, writing and dissemination of this content.
References:
1. Please refer to the technical report entitled “NI 43-101 Technical Report and Prefeasibility Study for the Madsen Mine, Ontario, Canada”, prepared by SRK Consulting (Canada) Inc. and dated January 7, 2025. A full copy of the SRK report is available on the Company’s website and on SEDAR+ at www.sedarplus.ca.
2. See PFS Section 16.5.3 Mining Methods – Underground Mining Methods – Planned Mining Methods.
Media Contact
Organization: Global Stocks News
Contact Person: guy.bennett@globalstocksnews.com
Website: https://www.globalstocksnews.com
Email: Send Email
Country:Canada
Release id:32056
The post West Red Lake Gold Generates July Gold Sales of CND $164 Million in Madsen Mine Ramp-up Phase appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Cloudbet Academy Launches World Cup 2026 Betting Guide: Crypto Strategies and Tournament Insights
Willemstad, Curaçao – Cloudbet, a leading crypto sportsbook and casino, today announces the release of the World Cup 2026 Betting Guide, a new free course in its Cloudbet Academy platform. Designed specifically for crypto users, this 35-minute open-access guide delivers targeted strategies and practical insights to help bettors navigate the expanded 48-team FIFA World Cup 2026, scheduled for June 11 to July 19, 2026.
The FIFA World Cup consistently ranks as one of the most heavily bet-on sporting events globally, attracting billions in wagers each edition due to its massive scale, international reach, and cultural impact. Industry estimates for recent tournaments place global betting turnover in the tens of billions of dollars, with projections for 2026 suggesting even higher volumes given the tournament’s unprecedented 48-team format and 104 matches.
A Cloudbet spokesperson says, “The 2026 World Cup is a prime moment for crypto bettors. On Cloudbet, with instant deposits and payouts in over 40 cryptocurrencies, you’re in the game within minutes. Stablecoins like USDT let you ride out volatility through the tournament, and low gas fees mean you can move fast when the odds shift. Want to back your country? Your club hero? You can, and with no red tape.”
Hundreds of outrights, player props, team specials, group winners, and other futures markets are already live on Cloudbet. These cover everything from tournament winner and top goalscorer to assists leader and match-specific propositions, giving users immediate access to a broad spectrum of options. For high-stakes bettors, Cloudbet’s Whale Mode—launched just in time for the Super Bowl—enables VIP traders to automate large positions with precision, making it ideal for high-profile tournaments like the World Cup.
The Academy, launched in late 2025, features three core tracks—Crypto Betting Basics, Sports Betting Fundamentals, and Betting Strategies & Analytics—that include interactive quizzes and rewards upon completion. The World Cup 2026 Betting Guide stands apart as the first tournament-specific course. It provides a focused, standalone deep dive that equips crypto users with crypto-optimized approaches to futures positioning, match betting, in-play tactics, and more.
World Cup 2026 Betting Guide: 7 Key Modules
The guide is structured across seven concise modules:
- World Cup 2026 basics and tournament format
Breaks down the expanded 48-team format and how it creates inefficiencies across early group pricing, qualification paths, and futures markets.
- World Cup outright & futures betting
Covers early positioning tactics, how to track odds shifts during qualification and the tournament, and how to use stablecoins to manage long-term volatility.
- How to place World Cup match bets
Introduces group-stage vs knockout-stage dynamics and teaches contextual analysis beyond surface-level rankings.
- World Cup props, specials & group-based markets
Focuses on Golden Boot, assist leaders, group winners, and other specials—plus how to adjust for neutral-venue effects.
- World Cup vs club football: What’s the difference?
Explains key differences in tempo, tactics, pressure, and bankroll management between international and club football.
- World Cup live betting strategies
Explores how to spot momentum swings in real time and use on-chain sentiment indicators to find edge in fast-moving markets.
- Advanced World Cup betting strategies & common mistakes (Advanced)
Covers sharp techniques like futures hedging, accumulator timing, and how to avoid common pitfalls like public sentiment chasing and overconfidence.
World Cup 2026 Qualification Snapshot
As of January 2026, 42 nations have qualified, including co-hosts USA, Canada, and Mexico, plus major teams from every confederation such as Spain, England, France, Argentina, Brazil, Japan, and Morocco. The December 2025 draw has set the groups, and six final spots will be decided in March 2026 through UEFA play-offs and the inter-confederation tournament in Mexico.
The Academy’s ‘World Cup Outright & Futures Betting‘ module covers more on this, including strategies for betting on group qualification, interpreting odds movements during play-offs, and positioning early in long-term markets amid uncertainty.
A Cloudbet spokesperson noted, “With groups locked in and just a few spots left, now’s the window where early odds still reflect uncertainty. This is when sharp bettors get in—before pricing tightens after March and public money floods the markets in June.”
Current World Cup 2026 Outright Odds on Cloudbet (as of January 2026)
● Spain: 5.55 odds
● England: 6.64 odds
● France: 8.99 odds
● Brazil: 9.11 odds
● Argentina: 9.13 odds
For the latest odds, visit Cloudbet.com.
Access the World Cup 2026 Betting Guide now at cloudbet.com/en/academy/world-cup-2026-betting-guide
About Cloudbet
Founded in 2013, Cloudbet is the world’s longest-running crypto sportsbook and casino. Players can bet with over 40 cryptocurrencies across thousands of sports markets and a full portfolio of casino games, including slots, live dealers, and provably fair crypto titles.
Cloudbet has processed millions of bets securely, offering sharp odds, high limits, instant crypto payouts, and 24/7 customer support.
In 2024, Cloudbet introduced a welcome offer and loyalty program built for serious players—real cash rewards, daily cash drops, and 10% rakeback with no wagering requirements.
From Premier League and NFL props to esports, tennis, and basketball, Cloudbet delivers the sharp action crypto bettors expect.
Find us at Cloudbet.com, on Instagram @cloudbetofficial, and Twitter/X @Cloudbet.
Media Contact
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Obtained China NDA Approval, Becoming The First and Only Targeted Drug for Vitiligo in China
SHENZHEN, CHINA – China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health which is applying for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited, please refer to the announcement published by the Group on 22 April 2025 for details) received approval from the National Medical Products Administration of China (NMPA) on 30 January 2026 for the New Drug Application (NDA) of ruxolitinib phosphate cream (the “Product”) for the treatment of non-segmental vitiligo with facial involvement in children aged 12 years and older and adult patients. It is the first and only targeted drug approved in China for vitiligo, addressing a significant unmet clinical need.
Ruxolitinib phosphate cream is the first and only drug approved by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for repigmentation in nonsegmental vitiligo[1,2]. Prior to receiving formal NDA approval, the Group benefited from the “Early and Pilot Implementation” policy granted to the Hainan Free Trade Port and Lecheng Pilot Zone (“Lecheng Pilot Zone”), the “Hong Kong and Macau Medicine and Equipment Connect” policy, and the clinically urgently needed imported drug policies of the Beijing and Tianjin Free Trade Zones, and had already initiated the pilot application of ruxolitinib phosphate cream. Currently, Boao Super Hospital has prescribed ruxolitinib phosphate cream to over 7,000 patients with non-segmental vitiligo, and more than twenty hospitals in Guangzhou, Shenzhen, Dongguan, Foshan, Zhongshan, Zhuhai, Jiangmen, Huizhou, Beijing and Tianjin have provided prescription services for the Product, demonstrating its clinical potential.
The product has shown positive results in both overseas clinical studies and the real-world study in China: in two identical Phase III double-blind, randomized, placebo-controlled studies (TRuE-V1 and TRuE-V2) conducted overseas, the proportion of patients achieving the primary efficacy endpoint of at least 75% improvement in the Facial Vitiligo Area Score Index (F-VASI 75) after 24 weeks of treatment with ruxolitinib phosphate cream was 29.9% in both studies, significantly higher than the 7.5% and 12.9% in the placebo groups, respectively. Continued use up to 52 weeks showed sustained repigmentation[3]. In accordance with the relevant regulations of the Lecheng Pilot Zone’s real-world data application pilot project, ruxolitinib phosphate cream underwent real-world study in China, demonstrating positive efficacy consistent with the results of overseas pivotal clinical studies. All secondary efficacy endpoints in both domestic and overseas clinical studies showed a benefit trend consistent with the primary efficacy endpoint, and the treatment effect for vitiligo continued to improve with prolonged treatment. Furthermore, according to safety monitoring data from the Lecheng Pilot Zone, no new safety event was identified, no adverse event (AE) leading to discontinuation or withdrawal of treatment occurred, and no study drug-related serious adverse event (SAE) occurred.
This approval in vitiligo brings new hope for treatment to over 10 million vitiligo patients in China, addressing urgent clinical needs. At the same time, it will add to Dermavon’s product portfolio in the field of skin treatment, potentially synergizing with Dermavon’s commercialized innovative drug ILUMETRI (tildrakizumab injection), commercialized exclusive drug Hirudoid (mucopolysaccharide polysulfate cream), and a series of innovative drugs under development and dermatological skin care products, in terms of expert network and market resources, thereby potentially enhancing Dermavon’s position in the field of skin health.
Furthermore, the Phase III clinical trial in China of ruxolitinib phosphate cream for the treatment of mild to moderate atopic dermatitis (AD) has achieved positive results. Currently, the Group is actively advancing the NDA for ruxolitinib phosphate cream for the treatment of AD in China, which, if approved, will provide a new treatment option for a broader patient population with AD in China.
About Vitiligo
Vitiligo is a chronic autoimmune disease characterized by depigmentation of the skin, which results from the loss of pigment-producing cells known as melanocytes. It is estimated that there are approximately 10.3 million vitiligo patients in China and non-segmental vitiligo patients account for approximately 8.2 million[4]. Existing therapies, such as topical corticosteroids (TCS) and topical calcineurin inhibitors (TCIs), have clinical limitations, with adverse reactions or limited efficacy with long-term use. The NDA approval of ruxolitinib phosphate cream successfully fills the gap in targeted drug treatment for vitiligo and is of great landmark significance.
More About Ruxolitinib Phosphate Cream
Ruxolitinib phosphate cream (Opzelura®), a novel cream formulation of the selective JAK1/JAK2 inhibitor ruxolitinib developed by Incyte, is approved for the topical treatment of nonsegmental vitiligo in adult and patients aged 12 years and older, and for the short-term and non-continuous chronic treatment of mild to moderate AD in patients aged 2 years and older without immunodeficiency in the U.S. In Europe, ruxolitinib phosphate cream is approved for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age.
The Group, through a subsidiary of Dermavon entered into a Collaboration and License Agreement with Incyte for ruxolitinib phosphate cream on 2 December 2022, obtaining an exclusive license to develop, register and commercialize the Product in Mainland China, Hong Kong Special Administrative Region, Macau Special Administrative Region, Taiwan Region and eleven Southeast Asian countries (the “Territory”) and a non-exclusive license to manufacture the Product in the Territory. The subsidiary of Dermavon has sublicensed the relevant rights for the Product outside Mainland China to the Group (excluding Dermavon and its subsidiary).
Incyte has worldwide rights for the development and commercialization of ruxolitinib phosphate cream, marketed in the United States and Europe as Opzelura®. Opzelura® and the Opzelura® logo are registered trademarks of Incyte.
About CMS
CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.
CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.
CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardio-cerebrovascular/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.
Reference:
- The U.S. FDA approval information can be found on the Incyte official website, as follows:
- The EMA approval information can be found on the Incyte official website, as follows:
- The clinical studies information can be found on the Opzelura® official website, as follows:
https://www.opzelura.com/opzelura-prescribing-information
- China Insights Consultancy’s industrial report
CMS Disclaimer and Forward-Looking Statements
This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.
This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.
Media Contact
Brand: China Medical System Holdings Ltd.
Contact: CMS Investor Relations
Email: ir@cms.net.cn
Website: https://web.cms.net.cn/en/home/
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Gabriel Malkin Florida Completes 120-Mile Camino Walk with Focus, Patience, and Preparation
Florida, US, 30th January 2026, ZEX PR WIRE, Most students don’t spend the start of summer walking across northern Spain. Gabriel Malkin did. In June 2025, the Florida high school graduate completed a 120-mile stretch of the Camino de Santiago, one of the world’s oldest pilgrimage routes. It wasn’t a last-minute idea. It was a goal he had planned for, trained for, and quietly worked toward for months.
This wasn’t about adventure or social media. For Gabriel, it was about setting a physical goal and showing up for it every day.
“I didn’t want to wing it,” he said. “It was important to take it seriously.”
Gabriel’s prep started long before his flight to Europe. He built up mileage slowly, starting with short daily walks in South Florida. As the months went on, he added distance, tested gear, and paid attention to recovery. Blisters, sore muscles, and weather were all part of the process. So was building patience.
“The Camino isn’t just hard because it’s long,” Gabriel said. “It’s hard because you have to get up and do it again every day. Even when you’re tired. Even when nothing hurts and you feel fine—you still have to walk.”
The daily rhythm became its own challenge. Mornings often started before sunrise, with quiet stretches of trail through farmland, hills, and towns. Gabriel carried a small pack with essentials. Water, snacks, extra socks. No Wi-Fi. No schedule beyond the day’s distance. Just a clear goal and a few hours of steady effort.
That focus and consistency mirrors how Gabriel approaches most things. Whether he’s in class, on the tennis court, or working on saxophone tone, he tends to favor structure and repetition over shortcuts. It’s not about perfection. It’s about showing up, improving slowly, and staying with it.
“I’ve never been the fastest or the strongest at anything,” he said. “But I like knowing I’m getting better, even if it’s slow.”
Gabriel grew up in South Florida and attended Virginia Shuman Young Elementary, Pine Crest in Fort Lauderdale, and NSU University School in Davie. He played tennis, baseball, and football through different stages of school. He also spent time hiking local trails and practicing saxophone, two interests he says helped him train for the Camino more than people might expect.
“Hiking helped with endurance, obviously,” he said. “But playing music teaches you a lot about repetition and listening to your body. You learn when to push and when to pause.”
For Gabriel, the Camino wasn’t a performance or a competition. It was a quiet personal test. He kept notes during the walk, not for a blog, but to track how each day felt. When he crossed the finish line in Santiago, there was no big moment. Just a quiet sense of completion.
Now back home, Gabriel hasn’t stopped walking. He’s back to local trails, early mornings, and training logs. He’s also thinking about what comes next—college, travel, more endurance goals—but isn’t rushing anything.
“There’s no rush,” he said. “The Camino reminded me that showing up every day matters more than trying to get somewhere fast.”
Gabriel Malkin Florida continues to build habits rooted in preparation, consistency, and follow-through. Whether through athletics, academics, or music, his focus remains steady: stay curious, stay active, and finish what you start.
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Cloudbet Academy Launches World Cup 2026 Betting Guide: Crypto Strategies and Tournament Insights
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Obtained China NDA Approval, Becoming The First and Only Targeted Drug for Vitiligo in China
Gabriel Malkin Florida Completes 120-Mile Camino Walk with Focus, Patience, and Preparation
Benzinga Money Article Discusses How to Become Part of the 12% of Retirees Who Have Achieved the Recommended $550,000 Minimum Retirement Savings Threshold
Apu Apustaja Conquers New York with Lively Street Ads, Including Times Square Billboard
Bay Smokes Maintains Quality Amid Legislative Changes in the Hemp Industry
-
Press Release7 days ago
Knybel Network Launches Focused Growth Campaign to Help Southeast Michigan Buyers and Homeowners Win in a Competitive Housing Market
-
Press Release7 days ago
New Findings Reveal a Hidden Indoor Air Quality Crisis Linked to Aging HVAC Systems and Fiberglass Ductwork Across South Florida
-
Press Release7 days ago
Stockity Arrives in Indonesia, Bringing Global Markets Closer to Local Traders
-
Press Release7 days ago
Karviva Selected to Meet with Costco Wholesale Southern California Merchants at Upcoming Local Summit
-
Press Release7 days ago
GOD55 Sports Announced as Gold Partner and Official Sports Media Partner for WPC Malaysia Series 2025-26
-
Press Release7 days ago
Rankiteo Opens Global Tender for Cyber Insurers: Exclusive Access to 5 million Enterprise Profiles and the Future of Cyber Insurance Distribution
-
Press Release7 days ago
Inside Bengaluru’s New Urban Escape: How Casasaga Is Redefining City Staycations
-
Press Release7 days ago
EvilBitcoin $EVIL Emerges on Solana as a Meme-First Crypto Movement Fueled by Culture, Community, and Internet Energy